Eps8 regulates cellular proliferation and migration of breast cancer

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 205-214

  Chen, Cheng ^a   Liang, Zhongheng ^a   Huang, Wenhuan ^a   Li, Xinxin ^b   Zhou, Fangliang ^a   Hu, Xiang ^a   Han, Mei ^a   Ding, Xiaofeng ^a   Xiang, Shuanglin ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Breast cancer; Cellular growth and migration; Cisplatin; E cadherin; EGF receptor substrate 8; Epithelial to mesenchymal transition; Extracellular signal regulated protein kinase; F actin; Lentiviral RNAi system; N cadherin; P53; Vimentin

Indexed keywords

EPS8 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MCF 7 CELL LINE; MEDULLARY CARCINOMA; MIDDLE AGED; MOUSE; NUDE MOUSE; PAGET NIPPLE DISEASE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84917696607     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2710     Document Type: Article

References (39)

1. Bray F, McCarron P and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6: 229-239, 2004.
2. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
3. Dahiya R and Deng G: Molecular prognostic markers in breast cancer. Breast Cancer Res Treat 52: 185-200, 1998.
4. Ross JS and Fletcher JA: The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist 3: 237-252, 1998.
5. Sgouros J, Galani E, Gonos E, et al: Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer. In Vivo 21: 519-522, 2007.
6. Barnes DM and Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15, 1998.
7. Wang H, Teh MT, Ji Y, et al: EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Carcinogenesis 31: 1132-1141, 2010.
8. Chen YJ, Shen MR, Chen YJ, Maa MC and Leu TH: Eps8 decreases chemosensitivity and affects survival of cervical cancer patients. Mol Cancer Ther 7: 1376-1385, 2008.
9. Maa MC, Lee JC, Chen YJ, et al: Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase. J Biol Chem 282: 19399-19409, 2007.
10. Wang H, Patel V, Miyazaki H, Gutkind JS and Yeudall WA: Role for EPS8 in squamous carcinogenesis. Carcinogenesis 30: 165-174, 2009.
11. Zhang W, Wang L, Liu Y, et al: Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev 23: 1387-1392, 2009.
12. Welsch T, Endlich K, Giese T, Buchler MW and Schmidt J: Eps8 is increased in pancreatic cancer and required for dynamic actinbased cell protrusions and intercellular cytoskeletal organization. Cancer Lett 255: 205-218, 2007.
13. Ding X, Zhou F, Wang F, et al: Eps8 promotes cellular growth of human malignant gliomas. Oncol Rep 29: 697-703, 2013.
14. Kang H, Wilson CS, Harvey RC, et al: Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 119: 1872-1881, 2012.
15. Matoskova B, Wong WT, Salcini AE, Pelicci PG and Di Fiore PP: Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol Cell Biol 15: 3805-3812, 1995.
16. Chu PY, Liou JH, Lin YM, et al: Expression of Eps8 correlates with poor survival in oral squamous cell carcinoma. Asia Pac J Clin Oncol 8: e77-e81, 2012.
17. Yang TP, Chiou HL, Maa MC and Wang CJ: Mithramycin inhibits human epithelial carcinoma cell proliferation and migration involving downregulation of Eps8 expression. Chem Biol Interact 183: 181-186, 2010.
18. Gorsic LK, Stark AL, Wheeler HE, et al: EPS8 inhibition increases cisplatin sensitivity in lung cancer cells. PLoS One 8: e82220, 2013.
19. Abdel-Rahman WM, Ruosaari S, Knuutila S and Peltomaki P: Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma. World J Gastroenterol 18: 3896-3903, 2012.
20. Li YH, Xue TY, He YZ and Du JW: Novel oncoprotein EPS8: a new target for anticancer therapy. Future Oncol 9: 1587-1594, 2013.
21. Yao J, Weremowicz S, Feng B, et al: Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 66: 4065-4078, 2006.
22. Mangravite LM, Lipschutz JH, Mostov KE and Giacomini KM: Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. Am J Physiol Renal Physiol 280: F879-F885, 2001.
23. Schmid JA, Birbach A, Hofer-Warbinek R, et al: Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. J Biol Chem 275: 17035-17042, 2000.
24. Lois C, Hong EJ, Pease S, Brown EJ and Baltimore D: Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872, 2002.
25. Ding X, Yang Z, Zhou F, et al: Transcription factor AP-2alpha regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression. Int J Biochem Cell Biol 45: 1647-1656, 2013.
26. Pan CC, Bloodworth JC, Mythreye K and Lee NY: Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation. Biochem Biophys Res Commun 424: 620-623, 2012.
27. Ridley AJ: Rho GTPases and cell migration. J Cell Sci 114: 2713-2722, 2001.
28. Scita G, Tenca P, Areces LB, et al: An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actinpolymerizing machine. J Cell Biol 154: 1031-1044, 2001.
29. Scita G, Nordstrom J, Carbone R, et al: EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401: 290-293, 1999.
30. Chen H, Wu X, Pan ZK and Huang S: Integrity of SOS1/EPS8/ ABI1 tri-complex determines ovarian cancer metastasis. Cancer Res 70: 9979-9990, 2010.
31. Hecquet C, Lefevre G, Valtink M, Engelmann K and Mascarelli F: Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci 43: 3091-3098, 2002.
32. Chang F, Steelman LS, Lee JT, et al: Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17: 1263-1293, 2003.
33. McCawley LJ, Li S, Wattenberg EV and Hudson LG: Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem 274: 4347-4353, 1999.
34. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442, 2003.
35. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
36. Grunert S, Jechlinger M and Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665, 2003.
37. Onder TT, Gupta PB, Mani SA, et al: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654, 2008.
38. Tanaka H, Kono E, Tran CP, et al: Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 16: 1414-1420, 2010.
39. Lang SH, Hyde C, Reid IN, et al: Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263, 2002.